SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b):
SEC Accession No. 0001193125-20-248702
Filing Date
2020-09-18
Accepted
2020-09-18 09:24:53
Documents
10
Period of Report
2020-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K12B d76627d8k12b.htm 8-K12B 46147
2 EX-3.1 d76627dex31.htm EX-3.1 51771
3 EX-3.2 d76627dex32.htm EX-3.2 144748
4 EX-4.1 d76627dex41.htm EX-4.1 70868
5 EX-4.2 d76627dex42.htm EX-4.2 71272
6 EX-10.1 d76627dex101.htm EX-10.1 39376
7 EX-10.2 d76627dex102.htm EX-10.2 70406
8 EX-10.3 d76627dex103.htm EX-10.3 33628
9 EX-14.1 d76627dex141.htm EX-14.1 40588
10 EX-99.1 d76627dex991.htm EX-99.1 9248
  Complete submission text file 0001193125-20-248702.txt   579905
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K12B | Act: 34 | File No.: 001-36866 | Film No.: 201182859
SIC: 2834 Pharmaceutical Preparations